Takeda Pharmaceutical announced its renewed investment in the Global Fund, making it the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment cycle.
The company started its partnership with the Global Fund in 2010 and today have announced that they will renew the partnership and contribute ¥1 billion (approximately US$9 million) over the next five years. The announcement shows their strong commitment to the Global Fund’s “Step Up the Fight” campaign. This investment is intended to fund the improvement of maternal and child health by integrating quality HIV, TB, and malaria services in antenatal and postnatal care in several priority countries in Africa.
FGFJ has served as the coordinator between the Global Fund and Takeda Pharmaceutical since 2010. Akio Okawara, director of FGFJ, noted, “Takeda’s continued commitment to support the global fight against the three diseases provides an exemplary model of private sector engagement and adds momentum to Japan’s public-private partnership efforts in promoting universal health coverage and achieving the SDGs.”
For more information
Global Fund press announcement: English / Japanese
Takeda Pharmaceutical Company announcement
FGFJ Information on Takeda Initiative
